MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0036595
Kantil Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹29.42 Cr
▲ 924% YoY
Net profit · FY 2024
₹36.79 Lakh
Net margin 1.3%
EBITDA · FY 2024
₹2.62 Cr
EBITDA margin 8.9%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹35 Lakh
Issued & subscribed
Open charges
₹45.62 Cr
Satisfied ₹12.75 Cr
Company age
5 yrs
Est. 2021
Employees · EPFO
33
Provident fund records
About Kantil Pharmaceuticals Private Limited
Data last updated:
Kantil Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2021PTC387973. Its GSTIN is 07AAJCK0870E1ZN (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors including Shikha Gupta and Nitin Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5 Raj Nagar Pitam Pura, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.42 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹36.79 Lakh (net margin 1.3%) and EBITDA of ₹2.62 Cr (EBITDA margin 8.9%).
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: KanTil Pharmaceuticals. As per MCA filings, the company has open charges of ₹45.62 Cr and satisfied charges of ₹12.75 Cr on record. Court records list 9 cases involving the company, including 5 filed by the company and 4 filed against it; 8 cases are pending.
Kantil Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0036595). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kantil.in.
Company details
CIN U24230DL2021PTC387973
Registration Number 387973
Incorporation Date 08 October 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0036595
Recognitions & Rankings of Kantil Pharmaceuticals
Contact details
Kantil Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is kantil.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address5 Raj Nagar Pitam Pura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kantil Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kantil Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kantil Pharmaceuticals operates one associated brand: KanTil Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, distribution, and R&D services in India. | kantil.in |
Business activity
The main business activity of Kantil Pharmaceuticals is manufacturing. In detail, this covers manufacture of leather and related products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 15 | Manufacture of leather and related products |
To see the full business activity and turnover split of Kantil Pharmaceuticals Private Limited, buy the company report.
Financials of Kantil Pharmaceuticals Private Limited
FY 2025 filings availableKantil Pharmaceuticals Private Limited reported revenue of ₹29.42 Cr (up 924% YoY) for FY 2024.
Revenue · FY 2024
₹29.42 Cr ▲ 924%
Net profit · FY 2024
₹36.79 Lakh margin 1.3%
EBITDA · FY 2024
₹2.62 Cr margin 8.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 924%
Revenue rose 924% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.62 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹36.79 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8.9% | ||
| Net Profit Margin | 1.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Kantil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kantil Pharmaceuticals Private Limited
Kantil Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shikha Gupta Also directs: Shinit Ventures LLP | Director | 08 Oct 2021 | 5 Years 0 Months | Current |
| Nitin Gupta Also directs: Avecia Biological LLP, Shinit Ventures LLP, Integra Health International LLP and 1 more | Director | 08 Oct 2021 | 5 Years 0 Months | Current |
| Sarika Gupta Also directs: Kantil Formulations Private Limited | Director | 08 Apr 2022 | 4 Years 6 Months | Current |
Auditor
Kantil Pharmaceuticals Private Limited is audited by S P H AND CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P H AND CO. | FY 2023 | 031201N |
Shareholding
The shareholding of Kantil Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kantil Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹45.62 Cr
Satisfied charges
₹12.75 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Dec 2025 | 101209918 | Others | ₹26.35 Cr | Open | |
| 27 Mar 2025 | 101078260 | Others | ₹5 Cr | Open | |
| 27 Mar 2025 | 101078274 | Others | ₹11.5 Cr | Open | |
| 04 Mar 2023 | 100721789 | Hdfc Bank Limited | ₹7.29 Lakh | Open | |
| 06 Oct 2022 | 100625380 | Hdfc Bank Limited | ₹2.7 Cr | Open |
To see the full charge records of Kantil Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Kantil Pharmaceuticals Private Limited has 9 court cases on record: 5 filed by Kantil Pharmaceuticals, 4 filed against it. 8 cases are pending and 1 is disposed.
Total cases
9
Filed by the company
5
Filed against the company
4
Pending
8
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 4 | 8 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by State at the Instance of Assistant Drugs Controller | Pending |
| District court, Kanpur Nagar, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
| District court, Sirmaur, Himachal Pradesh | Court case (Complaint IPC pvt. Complaint) | Filed against the company by an individual | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Aryan Life Heathcare Pvt. Ltd. and 2 others | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against M/S Embit Bio Madix and 2 others | Pending |
To see the full case history of Kantil Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kantil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kantil Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCK0870E1ZN | Delhi | Active | 31 Oct 2021 |
| 02AAJCK0870E1ZX | Himachal Pradesh | Active | 24 Nov 2021 |
To see the full GST registrations and return filing status of Kantil Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kantil Pharmaceuticals Private Limited has 5 board changes on record since 2021: 4 appointments and 1 cessation. The latest: Sachin Gupta ceased to be Director on 30 Jun 2023.
Charges
A charge with Others amounted to Rs. 2,635.00 Lakh with Charge ID 101209918 was registered on 29 Dec 2025.
AGM
Kantil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 29 Mar 2022 via Charge ID 100563338 with Hdfc Bank Limited was fully satisfied on 22 Jul 2025.
Filing
Kantil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 101078260 was registered on 27 Mar 2025.
Charges
A charge with Others amounted to Rs. 1,150.20 Lakh with Charge ID 101078274 was registered on 27 Mar 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 1,275.00 Lakh registered on 29 Mar 2022 with Charge ID 100563338 was modified on 30 Jan 2024.
Ceased
Sachin Gupta ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.29 Lakh with Charge ID 100721789 was registered on 04 Mar 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 270.00 Lakh with Charge ID 100625380 was registered on 06 Oct 2022.
Appointed
Sachin Gupta was appointed as Director.
Appointed
Sarika Gupta was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Kantil Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 October 2021 (5+ years old) and is registered under CIN U24230DL2021PTC387973.
Kantil Pharmaceuticals has 3 current directors:
- Shikha Gupta - Director
- Nitin Gupta - Director
- Sarika Gupta - Director
The latest financial statements of Kantil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Kantil Pharmaceuticals is 07AAJCK0870E1ZN, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAJCK0870E1ZX (Himachal Pradesh).
The CIN (Corporate Identification Number) of Kantil Pharmaceuticals is U24230DL2021PTC387973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kantil Pharmaceuticals has 9 court cases on record: 5 filed by the company and 4 filed against it. 8 are pending.
Kantil Pharmaceuticals was incorporated on 08 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Sachin Gupta ceased to be Director on 30 Jun 2023. Sachin Gupta was appointed as Director on 08 Apr 2022. Sarika Gupta was appointed as Director on 08 Apr 2022. Kantil Pharmaceuticals has 5 board changes on record in total.
Yes, Kantil Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0036595).
Kantil Pharmaceuticals can be reached through the website kantil.in. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages